Literature DB >> 9097917

Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis.

P Pantelidis1, A M Southcott, C M Black, R M Du Bois.   

Abstract

Neutrophil accumulation in the lower respiratory tract of patients with fibrosing alveolitis is thought to be facilitated by IL-8, a neutrophil chemoattractant primarily secreted by mononuclear phagocytes. The aims of this study were: (i) to explore IL-8 secretion by lung and blood mononuclear phagocytes in subjects with cryptogenic fibrosing alveolitis, systemic sclerosis with and without fibrosing alveolitis, sarcoidosis and normal individuals; (ii) to examine IL-8 secretory heterogeneity in alveolar macrophages and peripheral blood monocytes; and (iii) to correlate alveolar macrophage phenotypic profile to IL-8 secretion. We observed that more monocytes secreted IL-8 than autologous macrophages and that there was heterogeneity in the in vitro IL-8 secretion by alveolar macrophages and peripheral blood monocytes. IL-8 secretion by alveolar macrophages was significantly higher in subjects with fibrosing alveolitis compared with subjects without fibrosing alveolitis, due to a higher percentage of IL-8-secreting alveolar macrophages in the fibrotic group both in the absence (P < 0.002) and presence of lipopolysaccharide (LPS) (P < 0.04) and correlated with bronchoalveolar lavage neutrophil percentage. Using the MoAbs RFD1, RFD7 and RFD9, that distinguish subsets of alveolar macrophages, we have been able to identify associations between secretion of IL-8 and smaller cells and the cells identified by the MoAb RFD7. In situ hybridization of the bronchoalveolar lavage cell population revealed that alveolar macrophages are the predominant source of IL-8 in the lung. We conclude that there is an increased number of IL-8-secreting alveolar macrophages in the lungs of patients with fibrosing alveolitis, and IL-8 secretion by these cells is associated with specific phenotypic profile expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097917      PMCID: PMC1904618          DOI: 10.1046/j.1365-2249.1997.d01-986.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

Review 1.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.

Authors:  L C W Lit; C K Wong; L S Tam; E K M Li; C W K Lam
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

3.  The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration.

Authors:  Hidekata Yasuoka; Yukie Yamaguchi; Carol A Feghali-Bostwick
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-08       Impact factor: 6.914

Review 4.  Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.

Authors:  Shui-Lian Yu; Woon-Pang Kuan; Chun-Kwok Wong; Edmund K Li; Lai-Shan Tam
Journal:  Clin Dev Immunol       Date:  2012-01-23

5.  Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific.

Authors:  P Pantelidis; D S McGrath; A M Southcott; C M Black; R M du Bois
Journal:  Respir Res       Date:  2001-10-08

6.  Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients.

Authors:  Tiago Carvalheiro; Sara Horta; Joel A G van Roon; Mariana Santiago; Maria J Salvador; Hélder Trindade; Timothy R D J Radstake; José A P da Silva; Artur Paiva
Journal:  Inflamm Res       Date:  2017-11-10       Impact factor: 4.575

7.  Extracellular acidification-induced CXCL8 production through a proton-sensing receptor OGR1 in human airway smooth muscle cells: a response inhibited by dexamethasone.

Authors:  Maiko Kadowaki; Hidenori Yamada; Koichi Sato; Hiroko Shigemi; Yukihiro Umeda; Miwa Morikawa; Yuko Waseda; Masaki Anzai; Yosuke Kamide; Haruka Aoki-Saito; Takeshi Hisada; Fumikazu Okajima; Tamotsu Ishizuka
Journal:  J Inflamm (Lond)       Date:  2019-02-19       Impact factor: 4.981

8.  Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.

Authors:  Katrin Schmidt; Lorena Martinez-Gamboa; Susan Meier; Christian Witt; Christian Meisel; Leif G Hanitsch; Mike O Becker; Doerte Huscher; Gerd R Burmester; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2009-07-17       Impact factor: 5.156

9.  Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis.

Authors:  Agnieszka Nielepkowicz-Goździńska; Wojciech Fendler; Ewa Robak; Lilianna Kulczycka-Siennicka; Paweł Górski; Tadeusz Pietras; Ewa Brzeziańska; Adam Antczak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02-04       Impact factor: 4.291

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.